ArticleVaccines2024

Monitoring the Risk of Type-2 Circulating Vaccine-Derived Poliovirus Emergence During Roll-Out of Type-2 Novel Oral Polio Vaccine.

Corey M Peak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.